Overview

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceuticals. The company is dedicated to addressing complex pharmaceutical needs and operates with a focus on niche markets. With a robust pipeline, ANI Pharmaceuticals is committed to providing innovative solutions to enhance patient care.

Therapeutic areas

API / Drug Master Files

ANI Pharmaceuticals, Inc. holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • LITHIUM CARBONATE PILOT PROCESSInactive1980-04-07

FDA compliance signals

13 FDA enforcement records linked to this company.

  • recall — Class II2026-05-27

    Defective Container; packets were found to be either empty or partially full.

  • recall — Class II2022-02-23

    cGMP Deviations

  • recall — Class II2022-02-23

    cGMP Deviations

  • recall — Class II2022-02-23

    cGMP Deviations

  • recall — Class II2022-02-23

    cGMP Deviations

  • recall — Class II2022-02-23

    cGMP Deviations

  • recall — Class III2020-10-28

    Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

  • recall — Class III2020-10-28

    Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

  • recall — Class III2020-10-28

    Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

  • recall — Class III2020-10-28

    Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

  • recall — Class III2020-10-28

    Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

  • recall — Class III2020-10-28

    Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

  • 4832016-07-28

    Late submission of 15-day report

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.